Psoriasis occurring in amelanotic lesions.
Hwang
S M
SM
Ahn
S K
SK
Choi
E H
EH
D000287:Administration, Topical; D000328:Adult; D000417:Albinism / Q000150:complications* / Q000473:pathology; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D016589:Astemizole / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011701:PUVA Therapy; D011239:Prednisolone / Q000031:analogs & derivatives / Q000627:therapeutic use; D011565:Psoriasis / Q000150:complications* / Q000473:pathology; D013472:Sunlight / Q000009:adverse effects; D014820:Vitiligo / Q000150:complications* / Q000188:drug therapy / Q000473:pathology
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D016589:Astemizole; D011239:Prednisolone; C035287:prednicarbate